Technology II
MSC外泌體用於肺發炎的治療與應用專利
MSC Exosome Therapy for Lung Inflammation
MSC Exosome Therapy for Lung Inflammation – Patent and Application.
Our proprietary MSC-derived exosome technology is designed to treat lung inflammation. It leverages the natural anti-inflammatory and regenerative properties of MSC exosomes. This technology enhances the therapeutic potential of exosomes in mitigating lung injury, promoting tissue repair, and reducing inflammatory responses.
This breakthrough innovation has been granted a Taiwan patent (Patent No. I852177), titled "Method for Treating Lung Injury," highlighting its clinical potential in regenerative medicine and inflammatory lung disease treatments.